Re: Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer

Samir S. Taneja

doi:10.1016/j.juro.2018.05.116

Re: Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer

Samir S. Taneja

Biomedical Engineering

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	498-499
Number of pages	2
Journal	The Journal of urology
Volume	200
Issue number	3
DOIs	https://doi.org/10.1016/j.juro.2018.05.116
State	Published - Sep 1 2018

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.juro.2018.05.116

Cite this

@article{c5f41d04ff284cecb8a833ea19a49a8c,

title = "Re: Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer",

author = "Taneja, {Samir S.}",

year = "2018",

month = sep,

day = "1",

doi = "10.1016/j.juro.2018.05.116",

language = "English (US)",

volume = "200",

pages = "498--499",

journal = "The Journal of urology",

issn = "0022-5347",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - Re

T2 - Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer

AU - Taneja, Samir S.

PY - 2018/9/1

Y1 - 2018/9/1

UR - http://www.scopus.com/inward/record.url?scp=85056386948&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056386948&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2018.05.116

DO - 10.1016/j.juro.2018.05.116

M3 - Comment/debate

C2 - 30412981

AN - SCOPUS:85056386948

SN - 0022-5347

VL - 200

SP - 498

EP - 499

JO - The Journal of urology

JF - The Journal of urology

IS - 3

ER -

Re: Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this